NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Coherus BioSciences Inc (F: 8C5)

 
8C5 Technical Analysis
5
As on 23rd Jan 2026 8C5 STOCK Price closed @ 1.81 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.04 & Strong Buy for SHORT-TERM with Stoploss of 1.33 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

8C5STOCK Price

Open 1.52 Change Price %
High 1.81 1 Day 0.47 35.07
Low 1.52 1 Week 0.38 26.57
Close 1.81 1 Month 0.77 74.04
Volume 7818 1 Year 0.63 53.39
52 Week High 2.00 | 52 Week Low 0.61
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
NT5 1000000.00 4629529.50%
NT5 1000000.00 4629529.50%
NT5 1000000.00 4629529.50%
30T 1000000.00 3759298.50%
 
F Germany Top Losers Stocks
BT81 0.00 -100.00%
BT81 0.00 -100.00%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
 
 
8C5
Daily Charts
8C5
Intraday Charts
Whats New @
Bazaartrend
8C5
Free Analysis
 
8C5 Important Levels Intraday
RESISTANCE2.37
RESISTANCE2.19
RESISTANCE2.08
RESISTANCE1.97
SUPPORT1.65
SUPPORT1.54
SUPPORT1.43
SUPPORT1.25
 
8C5 Forecast January 2026
4th UP Forecast2.6
3rd UP Forecast2.35
2nd UP Forecast2.19
1st UP Forecast2.03
1st DOWN Forecast1.59
2nd DOWN Forecast1.43
3rd DOWN Forecast1.27
4th DOWN Forecast1.02
 
8C5 Weekly Forecast
4th UP Forecast3.70
3rd UP Forecast3.09
2nd UP Forecast2.72
1st UP Forecast2.34
1st DOWN Forecast1.28
2nd DOWN Forecast0.90
3rd DOWN Forecast0.53
4th DOWN Forecast-0.08
 
8C5 Forecast2026
4th UP Forecast4.72
3rd UP Forecast3.79
2nd UP Forecast3.21
1st UP Forecast2.63
1st DOWN Forecast0.99
2nd DOWN Forecast0.41
3rd DOWN Forecast-0.17
4th DOWN Forecast-1.1
 
Coherus BioSciences Inc ( F Germany Symbol : 8C5 )
Sector : N/A And Other Stocks in Same Sector
 
8C5 Other Details
Segment EQ
Market Capital 982918784.00
Sector
Industry
Offical website >
 
8C5 Address
8C5
 
8C5 Latest News
 
Your Comments and Response on Coherus BioSciences Inc
 
8C5 Business Profile
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline includes biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar; and CHS-131, a once-daily oral drug candidate for non-alcoholic steatohepatitis and other metabolic conditions. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California. Address: 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service